Cultivar Variants · Tea Cultivars
Matcha Uji Green Tea (Camellia sinensis 'Matcha Uji')
Preliminary EvidenceCompound
Hermetica Superfood Encyclopedia
Matcha Uji Green Tea (Camellia sinensis 'Matcha Uji') is a shade-grown Japanese cultivar exceptionally rich in L-theanine and EGCG (epigallocatechin gallate), which synergistically modulate alpha brain wave activity and inhibit catechol-O-methyltransferase (COMT) to sustain catecholamine signaling. These bioactives collectively support cognitive function, stress resilience, and gut microbiota balance as demonstrated in controlled human trials.
Matcha Uji is a shade-grown cultivar of Camellia sinensis originating from the Uji region of Japan, where tea plants are shaded from direct sunlight for several weeks before harvest to increase chlorophyll and amino acid content. The leaves are stone-ground into a fine powder rather than steeped and removed, making the entire leaf available for consumption with exceptionally high levels of antioxidants including flavonoids (1968.8 mg/L), polyphenols (1765.1 mg/L), and vitamin C (44.8 mg/L).
A 12-month randomized, double-blind, placebo-controlled trial (PMID: 39213264) in 60-85 year old adults with mild cognitive impairment showed matcha improved emotional perception and sleep quality with 98-99% compliance. A 2-week RCT (PMID: 36936880) in 33 participants demonstrated significant changes in gut microbiota beta-diversity, with 30 unique bacterial genera altered in the matcha group versus only 3 in placebo.
Clinical studies used 1.5g matcha powder in capsule form, prepared as drinks twice daily (morning and evening). The 12-month cognitive trial achieved 98-99% intake compliance with capsule formulations, verified by red blood cell theanine levels. Consult a healthcare provider before starting any new supplement.
Matcha Uji is a shade-grown, stone-ground whole-leaf green tea powder with a uniquely concentrated nutritional profile compared to steeped teas, as the entire leaf is consumed. Per 1g serving (approximately 1/2 tsp): Calories ~3 kcal; Protein ~0.3g (notably higher than steeped tea due to whole-leaf consumption); Carbohydrates ~0.5g; Fat ~0.05g; Fiber ~0.3g. Key bioactive compounds: L-theanine ~6–9mg/g (exceptionally high in Uji-region shade-grown cultivars due to extended shading increasing L-theanine synthesis); Catechins (total) ~45–65mg/g, predominantly Epigallocatechin gallate (EGCG) ~25–35mg/g, Epicatechin gallate (ECG) ~5–8mg/g, Epigallocatechin (EGC) ~5–10mg/g; Caffeine ~19–44mg/g (typically ~27mg per 1g serving); Chlorophyll a and b ~6–10mg/g (elevated due to shade-growing increasing chlorophyll production); Theogallin and other polyphenols present at trace levels. Vitamins: Vitamin C (ascorbic acid) ~1.8–2.5mg/g; Vitamin K1 (phylloquinone) ~22–29µg/g (notably bioavailable as whole leaf is consumed); Vitamin B2 (riboflavin) ~0.035mg/g; Vitamin E (alpha-tocopherol) ~0.28mg/g. Minerals: Manganese ~0.28mg/g (excellent source relative to serving); Potassium ~0.27mg/g; Calcium ~4.6mg/g; Iron ~0.17mg/g; Zinc ~0.06mg/g; Fluoride ~0.04mg/g. ORAC antioxidant value estimated at ~1,384 µmol TE per gram, approximately 10–15x higher than most other antioxidant-rich foods by weight. Bioavailability notes: EGCG bioavailability is enhanced versus steeped tea (whole-leaf consumption delivers ~3–5x more catechins); however, EGCG absorption remains moderate (~1–12%) and is improved when consumed without dairy proteins (casein binds catechins) and on an empty stomach. L-theanine is highly bioavailable (~95%) and crosses the blood-brain barrier efficiently. The L-theanine:caffeine ratio (~3:1 to 4:1 in quality Uji matcha) is considered optimal for producing calm alertness. Vitamin K content is clinically relevant for individuals on anticoagulant therapy. Heavy metals (notably lead) can concentrate in tea leaves; Uji-sourced matcha generally shows lower contamination than Chinese-origin products due to stricter Japanese agricultural standards.
L-theanine crosses the blood-brain barrier and increases alpha-wave oscillations while antagonizing AMPA and NMDA glutamate receptors, producing calm alertness without sedation. EGCG inhibits COMT, slowing the breakdown of dopamine and norepinephrine, and also suppresses NF-κB transcription to reduce neuroinflammatory cytokine production. Simultaneously, polyphenolic catechins act as prebiotics, selectively enriching butyrate-producing Coprococcus species while suppressing Fusobacterium via pH modulation and direct antimicrobial activity in the colon.
A 12-month randomized controlled trial (PMID: 39213264) in older adults with mild cognitive decline found that daily Matcha Uji supplementation significantly improved emotional perception and sleep quality compared to placebo. A 2-week RCT (PMID: 36936880) demonstrated measurable shifts in gut microbiota, specifically increased Coprococcus and decreased Fusobacterium, following regular intake. Additional evidence supports acute and chronic stress reduction, likely via L-theanine's modulation of cortisol and sympathetic tone. Overall evidence quality is moderate; trials are generally small-to-medium in sample size, and longer-term large-scale studies are needed to confirm durability of effects.
Matcha Uji contains approximately 30–70 mg of caffeine per gram of powder, which may cause insomnia, palpitations, or anxiety at high doses, particularly in caffeine-sensitive individuals. EGCG at doses above 800 mg/day has been associated with hepatotoxic effects in case reports, though typical culinary and supplement doses (200–400 mg EGCG equivalent) are generally considered safe. Matcha may interact with anticoagulants such as warfarin due to its vitamin K content and can reduce iron absorption when consumed with meals via catechin-iron chelation. Pregnant individuals should limit intake to moderate amounts owing to caffeine content, and those on MAO inhibitors or stimulant medications should consult a physician before use.
